Literature DB >> 10492686

Serum markers of brain damage and outcome prediction in patients after severe head injury.

A Raabe1, C Grolms, V Seifert.   

Abstract

The objective of the study was to investigate the validity of outcome prediction after severe head injury using serum levels of S-100B protein and neuron specific enolase. Eighty-two patients with severe head injury were included in this prospective study. Venous blood samples were taken after admission and every 24 h for a maximum of 10 consecutive days. For values of S-100 from 0 to 2.5 micrograms/l, and for values of NSE from 0 to 100 micrograms/l the sensitivity and specificity of incremental values as a predictor of unfavourable outcome were calculated and Receiver Operator Characteristics curves were plotted. Serum S-100 protein was found to be clearly superior to neuron specific enolase in terms of predicting outcome with higher specificity, sensitivity, positive and negative predictive value. According to our experience, S-100B protein represents the most promising serum marker of brain cell damage currently under investigation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10492686     DOI: 10.1080/02688699944195

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  29 in total

1.  Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention.

Authors:  Linda Papa; Lawrence M Lewis; Jay L Falk; Zhiqun Zhang; Salvatore Silvestri; Philip Giordano; Gretchen M Brophy; Jason A Demery; Neha K Dixit; Ian Ferguson; Ming Cheng Liu; Jixiang Mo; Linnet Akinyi; Kara Schmid; Stefania Mondello; Claudia S Robertson; Frank C Tortella; Ronald L Hayes; Kevin K W Wang
Journal:  Ann Emerg Med       Date:  2011-11-08       Impact factor: 5.721

Review 2.  Blood-based diagnostics of traumatic brain injuries.

Authors:  Stefania Mondello; Uwe Muller; Andreas Jeromin; Jackson Streeter; Ronald L Hayes; Kevin K W Wang
Journal:  Expert Rev Mol Diagn       Date:  2011-01       Impact factor: 5.225

3.  Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury.

Authors:  Linda Papa; Linnet Akinyi; Ming Cheng Liu; Jose A Pineda; Joseph J Tepas; Monika W Oli; Wenrong Zheng; Gillian Robinson; Steven A Robicsek; Andrea Gabrielli; Shelley C Heaton; H Julia Hannay; Jason A Demery; Gretchen M Brophy; Joe Layon; Claudia S Robertson; Ronald L Hayes; Kevin K W Wang
Journal:  Crit Care Med       Date:  2010-01       Impact factor: 7.598

4.  Predictive value of neuron-specific enolase for prognosis in patients with moderate or severe traumatic brain injury: a systematic review and meta-analysis.

Authors:  Eric Mercier; Amélie Boutin; Michèle Shemilt; François Lauzier; Ryan Zarychanski; Dean A Fergusson; Lynne Moore; Lauralyn A McIntyre; Patrick Archambault; France Légaré; François Rousseau; François Lamontagne; Linda Nadeau; Alexis F Turgeon
Journal:  CMAJ Open       Date:  2016-07-22

5.  Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats.

Authors:  Ming C Liu; Linnet Akinyi; Dancia Scharf; Jixiang Mo; Stephen F Larner; Uwe Muller; Monika W Oli; Wenrong Zheng; Firas Kobeissy; Linda Papa; Xi-Chun Lu; Jitendra R Dave; Frank C Tortella; Ronald L Hayes; Kevin K W Wang
Journal:  Eur J Neurosci       Date:  2010-02       Impact factor: 3.386

6.  Protein biomarkers for traumatic and ischemic brain injury: from bench to bedside.

Authors:  Zhiqun Zhang; Stefania Mondello; Firas Kobeissy; Richard Rubenstein; Jackson Streeter; Ronald L Hayes; Kevin K W Wang
Journal:  Transl Stroke Res       Date:  2011-12-07       Impact factor: 6.829

7.  Mild Traumatic Brain Injury among the Geriatric Population.

Authors:  Linda Papa; Matthew E Mendes; Carolina F Braga
Journal:  Curr Transl Geriatr Exp Gerontol Rep       Date:  2012-09-01

8.  Serum neuron-specific enolase as a predictor of short-term outcome and its correlation with Glasgow Coma Scale in traumatic brain injury.

Authors:  Aslan Guzel; Uygur Er; Mehmet Tatli; Ufuk Aluclu; Umit Ozkan; Yucel Duzenli; Omer Satici; Ebru Guzel; Serdar Kemaloglu; Adnan Ceviz; Abdurrahman Kaplan
Journal:  Neurosurg Rev       Date:  2008-06-17       Impact factor: 3.042

9.  The potential utility of blood-derived biochemical markers as indicators of early clinical trends following severe traumatic brain injury.

Authors:  Michael V DeFazio; Richard A Rammo; Jaime R Robles; Helen M Bramlett; W Dalton Dietrich; M Ross Bullock
Journal:  World Neurosurg       Date:  2013-01-08       Impact factor: 2.104

10.  Biomarkers improve clinical outcome predictors of mortality following non-penetrating severe traumatic brain injury.

Authors:  Linda Papa; Claudia S Robertson; Kevin K W Wang; Gretchen M Brophy; H Julia Hannay; Shelley Heaton; Ilona Schmalfuss; Andrea Gabrielli; Ronald L Hayes; Steven A Robicsek
Journal:  Neurocrit Care       Date:  2015-02       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.